S&P 500

5.631,22

0,28%

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

ARDX

Ardelyx (ARDX)

Ardelyx Inc

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ARDX

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
12/11/2021	14h00	PR Newswire (US)	Ardelyx Reports Third Quarter 2021 Financial Results	NASDAQ:ARDX	Ardelyx Inc
11/11/2021	22h05	PR Newswire (US)	Ardelyx to Present at the Jefferies London Healthcare Conference	NASDAQ:ARDX	Ardelyx Inc
10/11/2021	23h17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ARDX	Ardelyx Inc
05/11/2021	13h00	PR Newswire (US)	Ardelyx Reports Additional Positive Data Supporting Clinical Utility of Tenapanor at ASN's Kidney Week 2021	NASDAQ:ARDX	Ardelyx Inc
04/11/2021	13h00	PR Newswire (US)	Ardelyx to Pursue Formal Dispute Resolution for Tenapanor	NASDAQ:ARDX	Ardelyx Inc
30/10/2021	01h55	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ARDX	Ardelyx Inc
29/10/2021	14h00	PR Newswire (US)	Ardelyx Announces Four Tenapanor Presentations at ASN's Kidney Week 2021	NASDAQ:ARDX	Ardelyx Inc
13/10/2021	14h04	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ARDX	Ardelyx Inc
13/10/2021	14h00	PR Newswire (US)	Ardelyx Provides Corporate Update Following Type A Meeting with FDA	NASDAQ:ARDX	Ardelyx Inc
03/09/2021	14h00	PR Newswire (US)	Ardelyx Announces Publication of 52-Week Phase 3 PHREEDOM Trial	NASDAQ:ARDX	Ardelyx Inc
25/08/2021	00h09	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ARDX	Ardelyx Inc
25/08/2021	00h08	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ARDX	Ardelyx Inc
25/08/2021	00h08	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ARDX	Ardelyx Inc
25/08/2021	00h07	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ARDX	Ardelyx Inc
25/08/2021	00h07	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ARDX	Ardelyx Inc
25/08/2021	00h06	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ARDX	Ardelyx Inc
25/08/2021	00h06	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ARDX	Ardelyx Inc
17/08/2021	23h22	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ARDX	Ardelyx Inc
16/08/2021	08h31	TipRanks	Ardelyx Reports Mixed Q2 Results; Shares Decline 5.3%	NASDAQ:ARDX	Ardelyx Inc
13/08/2021	22h05	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:ARDX	Ardelyx Inc
13/08/2021	14h04	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:ARDX	Ardelyx Inc
13/08/2021	14h00	PR Newswire (US)	Ardelyx Reports Second Quarter 2021 Financial Results	NASDAQ:ARDX	Ardelyx Inc
05/08/2021	23h02	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ARDX	Ardelyx Inc
05/08/2021	23h02	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ARDX	Ardelyx Inc
03/08/2021	12h05	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ARDX	Ardelyx Inc
01/08/2021	12h07	TipRanks	Ardelyx Receives FDA Nod; Shares Pop 14.5%	NASDAQ:ARDX	Ardelyx Inc
30/07/2021	12h08	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ARDX	Ardelyx Inc
29/07/2021	22h01	PR Newswire (US)	Ardelyx Receives Complete Response Letter from U.S. FDA for New Drug Application for Tenapanor for the Control of Serum Phosphorus in Adult Patients with CKD on Dialysis	NASDAQ:ARDX	Ardelyx Inc
21/07/2021	22h52	TipRanks	Is There an Opportunity in Ardelyx Stock After Massive Selloff? Analyst Weighs In	NASDAQ:ARDX	Ardelyx Inc
20/07/2021	17h59	Dow Jones News	Ardelyx Down 74% After FDA Letter on Tenapanor	NASDAQ:ARDX	Ardelyx Inc